REQUEST A DEMO
Total
USD $0.00
Search more companies

Onkomedica Sp. z o.o. (Poland)

Main Activities: Ambulatory Health Care Services
Secondary Activities: Periodical Publishers | Book Publishers | Other Publishers | All Other Miscellaneous Schools and Instruction | Offices of Physicians | Offices of All Other Miscellaneous Health Practitioners | Outpatient Care Centers | All Other Miscellaneous Ambulatory Health Care Services | General Medical and Surgical Hospitals
Full name: Onkomedica Sp. z o.o. Profile Updated: May 26, 2024
Buy our report for this company USD 19.99 Most recent financial data: 2024 Available in: English & Polish Download a sample report

Onkomedica Sp. z o.o is a medical center specializing in providing diagnosis and multidisciplinary consultations for adult patients with diagnosed or suspected cancer diseases. The company serves English-speaking patients and offers comprehensive care through a team of professionals in various fields related to oncology.

Headquarters
Ul. Arkuszowa 73
Warsaw; Mazowieckie; Postal Code: 01-934

Contact Details: Purchase the Onkomedica Sp. z o.o. report to view the information.

Website: http://www.onkomedica.pl

Basic Information
Registered Capital:
Purchase the Onkomedica Sp. z o.o. report to view the information.
Financial Auditors:
Purchase the Onkomedica Sp. z o.o. report to view the information.
Incorporation Date:
April 20, 2022
Key Executives
Purchase this report to view the information.
President
Ownership Details
Purchase this report to view the information.
80%
Purchase this report to view the information.
20%
Company Performance
Financial values in the chart are available after Onkomedica Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
56.07%
Total operating revenue
56.07%
Operating profit (EBIT)
91.68%
EBITDA
97.06%
Net Profit (Loss) for the Period
91.68%
Total Assets
47.93%
Total Equity
-2.02%
Operating Profit Margin (ROS)
50.47%
Net Profit Margin
50.47%
Return on Equity (ROE)
-22.23%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?